Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRO-513 in Migraine Attack
NCT00330850Phase 3Completed
- Sponsor
- ProEthic Pharmaceuticals
- Start
- May 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of diclofenac potassium in migraine, sponsored by ProEthic Pharmaceuticals. Started May 2006; status: completed.
02
Drugs
diclofenac potassium
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00330850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00330850.